NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMENBm Sandmaier, R Strob, T Chauncey et al.|Blood|2001Cited by 39
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansionSalvatore Fiorenza, Cameron J. Turtle, Ye Zheng et al.|Nature Communications|2024Cited by 10
Nonmyeloablative conditioning for stem cell allografts with low-dose tbiBM Sandmaier, Rainer Storb, DG Maloney et al.|Experimental Hematology|2000Cited by 2